Advances in understanding angiogenesis through molecular studies

Mijung Kwon, Steven K. Libutti

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Tumors, in most cases, need angiogenesis for their sustained growth. A great deal of evidence has suggested that the process of angiogenesis is regulated by the balance between proangiogenic and antiangiogenic factors. Thus, the inhibition of tumor angiogenesis has been considered to be one of the key targets in anticancer therapy, and more than 60 antiangiogenic compounds are currently under clinical evaluation in cancer patients. However, the molecular mechanisms responsible for the activity of many of these antiangiogenic compounds are still not well understood. The recent development of microarray technology has allowed us to investigate the mechanism of action of these inhibitors more rapidly and extensively. With the use of microarray technology, novel molecules and pathways are shown to play a role in angiogenesis. This article also reviews new experimental approaches combined with microarray analysis to identify the molecular pathways involved in tumor-host interactions. Elucidation of the pathways that mediate both angiogenic and antiangiogenic responses will help us to develop better anticancer therapies.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume64
Issue number1
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

angiogenesis
tumors
therapy
Neoplasms
Technology
Microarray Analysis
inhibitors
cancer
evaluation
Therapeutics
Growth
molecules
interactions

Keywords

  • Angiogenesis
  • Antiangiogenic factors
  • Microarray analysis
  • Molecular pathways
  • Tumor-host interaction

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Advances in understanding angiogenesis through molecular studies. / Kwon, Mijung; Libutti, Steven K.

In: International Journal of Radiation Oncology Biology Physics, Vol. 64, No. 1, 01.01.2006, p. 26-32.

Research output: Contribution to journalArticle

@article{48035b002ae942b390398a349bcf90f4,
title = "Advances in understanding angiogenesis through molecular studies",
abstract = "Tumors, in most cases, need angiogenesis for their sustained growth. A great deal of evidence has suggested that the process of angiogenesis is regulated by the balance between proangiogenic and antiangiogenic factors. Thus, the inhibition of tumor angiogenesis has been considered to be one of the key targets in anticancer therapy, and more than 60 antiangiogenic compounds are currently under clinical evaluation in cancer patients. However, the molecular mechanisms responsible for the activity of many of these antiangiogenic compounds are still not well understood. The recent development of microarray technology has allowed us to investigate the mechanism of action of these inhibitors more rapidly and extensively. With the use of microarray technology, novel molecules and pathways are shown to play a role in angiogenesis. This article also reviews new experimental approaches combined with microarray analysis to identify the molecular pathways involved in tumor-host interactions. Elucidation of the pathways that mediate both angiogenic and antiangiogenic responses will help us to develop better anticancer therapies.",
keywords = "Angiogenesis, Antiangiogenic factors, Microarray analysis, Molecular pathways, Tumor-host interaction",
author = "Mijung Kwon and Libutti, {Steven K.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.ijrobp.2005.03.024",
language = "English (US)",
volume = "64",
pages = "26--32",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Advances in understanding angiogenesis through molecular studies

AU - Kwon, Mijung

AU - Libutti, Steven K.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Tumors, in most cases, need angiogenesis for their sustained growth. A great deal of evidence has suggested that the process of angiogenesis is regulated by the balance between proangiogenic and antiangiogenic factors. Thus, the inhibition of tumor angiogenesis has been considered to be one of the key targets in anticancer therapy, and more than 60 antiangiogenic compounds are currently under clinical evaluation in cancer patients. However, the molecular mechanisms responsible for the activity of many of these antiangiogenic compounds are still not well understood. The recent development of microarray technology has allowed us to investigate the mechanism of action of these inhibitors more rapidly and extensively. With the use of microarray technology, novel molecules and pathways are shown to play a role in angiogenesis. This article also reviews new experimental approaches combined with microarray analysis to identify the molecular pathways involved in tumor-host interactions. Elucidation of the pathways that mediate both angiogenic and antiangiogenic responses will help us to develop better anticancer therapies.

AB - Tumors, in most cases, need angiogenesis for their sustained growth. A great deal of evidence has suggested that the process of angiogenesis is regulated by the balance between proangiogenic and antiangiogenic factors. Thus, the inhibition of tumor angiogenesis has been considered to be one of the key targets in anticancer therapy, and more than 60 antiangiogenic compounds are currently under clinical evaluation in cancer patients. However, the molecular mechanisms responsible for the activity of many of these antiangiogenic compounds are still not well understood. The recent development of microarray technology has allowed us to investigate the mechanism of action of these inhibitors more rapidly and extensively. With the use of microarray technology, novel molecules and pathways are shown to play a role in angiogenesis. This article also reviews new experimental approaches combined with microarray analysis to identify the molecular pathways involved in tumor-host interactions. Elucidation of the pathways that mediate both angiogenic and antiangiogenic responses will help us to develop better anticancer therapies.

KW - Angiogenesis

KW - Antiangiogenic factors

KW - Microarray analysis

KW - Molecular pathways

KW - Tumor-host interaction

UR - http://www.scopus.com/inward/record.url?scp=29244485429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244485429&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2005.03.024

DO - 10.1016/j.ijrobp.2005.03.024

M3 - Article

VL - 64

SP - 26

EP - 32

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -